Grail GRAL
NASDAQ GRAL
$80.77 +0.82 (+1.03%)
At close: Sep 18, 2026 · 4:00 PM EDT

Grail (GRAL) Asset Writedowns and Impairment (2023 - 2026)

Grail's (GRAL) quarterly Asset Writedowns and Impairment came in at $25.4 million in Q2 2026, down 9.2% on a YoY basis from $28.0 million in Q2 2025, and up 10192.71% quarter-over-quarter from $247000.0 in Q1 2026.

Analysis

Grail (GRAL) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends

Grail (GRAL) has reported Asset Writedowns and Impairment for 4 consecutive years, with $25.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Asset Writedowns and Impairment fell 9.2% year-over-year to $25.4 million; the trailing twelve-month figure through Jun 2026 stood at $25.7 million (down 9.21% YoY), and the FY2025 full-year result was $28.0 million, down 98.03% from the prior year.
  • Asset Writedowns and Impairment climbed to $25.4 million in Q2 2026 per GRAL's latest filing, from $247000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.4 billion in Q2 2024 and bottomed at $247000.0 in Q1 2026.
  • Historically, Asset Writedowns and Impairment has averaged $365.6 million across 4 years, with a median of $26.7 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Asset Writedowns and Impairment tumbled 98.03% in 2025, then dropped 9.2% in 2026.
  • Over 4 years, Asset Writedowns and Impairment stood at $718.5 million in 2023, then jumped by 97.77% to $1.4 billion in 2024, then sank by 98.03% to $28.0 million in 2025, then decreased by 9.2% to $25.4 million in 2026.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $25.4 million, $247000.0, and $28.0 million for Q2 2026, Q1 2026, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Grail 3.61 Bn 2.75 Bn 21.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.42 Mn
Mar 31, 2026 247,000.00
Jun 30, 2025 28.00 Mn
Mar 31, 2025 273,000.00
Jun 30, 2024 1.42 Bn
Oct 1, 2023 718.47 Mn